130 related articles for article (PubMed ID: 10527248)
1. Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.
Robert R; Grollier G; Doré P; Hira M; Ferrand E; Fauchère JL
J Crit Care; 1999 Sep; 14(3):114-9. PubMed ID: 10527248
[TBL] [Abstract][Full Text] [Related]
2. Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study.
Manhold C; von Rolbicki U; Brase R; Timm J; von Pritzbuer E; Heimesaat M; Kljucar S
Intensive Care Med; 1998 Dec; 24(12):1327-30. PubMed ID: 9885888
[TBL] [Abstract][Full Text] [Related]
3. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study.
Marik PE; Careau P
Chest; 1999 Jan; 115(1):178-83. PubMed ID: 9925081
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
[TBL] [Abstract][Full Text] [Related]
5. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Vitkauskiene A; Sakalauskas R; Dudzevicius V
Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial sinusitis with isolation of anaerobic bacteria in ICU patients.
Le Moal G; Lemerre D; Grollier G; Desmont C; Klossek JM; Robert R
Intensive Care Med; 1999 Oct; 25(10):1066-71. PubMed ID: 10551960
[TBL] [Abstract][Full Text] [Related]
7. Modeling the response of pneumonia to antimicrobial therapy.
Hyatt JM; Luzier AB; Forrest A; Ballow CH; Schentag JJ
Antimicrob Agents Chemother; 1997 Jun; 41(6):1269-74. PubMed ID: 9174182
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of twice-daily cefotaxime in the treatment of hospitalized patients with severe infections.
Keller C
Diagn Microbiol Infect Dis; 1995; 22(1-2):159-61. PubMed ID: 7587032
[TBL] [Abstract][Full Text] [Related]
9. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
Shah PM; Stille W
Diagn Microbiol Infect Dis; 1995; 22(1-2):171-2. PubMed ID: 7587035
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Sun HK; Kuti JL; Nicolau DP
Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
[TBL] [Abstract][Full Text] [Related]
11. A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Amyes SG; Baird DR; Crook DW; Gillespie SH; Howard AJ; Oppenhiem BA; Pedler SJ; Paull A; Tompkins DS; Lawrie SA
J Antimicrob Chemother; 1994 Nov; 34(5):639-48. PubMed ID: 7706159
[TBL] [Abstract][Full Text] [Related]
12. The choice of empirical antibiotic therapy for nosocomial pneumonia.
Ramirez JA
J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
[TBL] [Abstract][Full Text] [Related]
13. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.
Kollef MH; Vlasnik J; Sharpless L; Pasque C; Murphy D; Fraser V
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1040-8. PubMed ID: 9351601
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
Torres A; Bauer TT; León-Gil C; Castillo F; Alvarez-Lerma F; Martínez-Pellús A; Leal-Noval SR; Nadal P; Palomar M; Blanquer J; Ros F
Thorax; 2000 Dec; 55(12):1033-9. PubMed ID: 11083889
[TBL] [Abstract][Full Text] [Related]
15. Pneumonia in mechanically ventilated children.
Brook I
Scand J Infect Dis; 1995; 27(6):619-22. PubMed ID: 8685643
[TBL] [Abstract][Full Text] [Related]
16. No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study.
Yayan J; Ghebremedhin B; Rasche K
BMC Infect Dis; 2015 Nov; 15():514. PubMed ID: 26567094
[TBL] [Abstract][Full Text] [Related]
17. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
[TBL] [Abstract][Full Text] [Related]
18. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
[TBL] [Abstract][Full Text] [Related]
19. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush.
Doré P; Robert R; Grollier G; Rouffineau J; Lanquetot H; Charrière JM; Fauchère JL
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1292-8. PubMed ID: 8616556
[TBL] [Abstract][Full Text] [Related]
20. The choice of antibacterial drugs.
Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
